Unknown

Dataset Information

0

Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system.


ABSTRACT: Enhancing central nervous system (CNS) myelin regeneration is recognized as an important strategy to ameliorate the devastating consequences of demyelinating diseases such as multiple sclerosis. Previous findings have indicated that myelin proteins, which accumulate following demyelination, inhibit remyelination by blocking the differentiation of rat oligodendrocyte progenitor cells (OPCs) via modulation of PKC?. We therefore screened drugs for their potential to overcome this differentiation block. From our screening, tamoxifen emerges as a potent inducer of OPC differentiation in vitro. We show that the effects of tamoxifen rely on modulation of the estrogen receptors ER?, ER?, and GPR30. Furthermore, we demonstrate that administration of tamoxifen to demyelinated rats in vivo accelerates remyelination. Tamoxifen is a well-established drug and is thus a promising candidate for a drug to regenerate myelin, as it will not require extensive safety testing. In addition, Tamoxifen plays an important role in biomedical research as an activator of inducible genetic models. Our results highlight the importance of appropriate controls when using such models.

SUBMITTER: Gonzalez GA 

PROVIDER: S-EPMC4995517 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system.

Gonzalez Ginez A GA   Hofer Matthias P MP   Syed Yasir A YA   Amaral Ana I AI   Rundle Jon J   Rahman Saifur S   Zhao Chao C   Kotter Mark R N MRN  

Scientific reports 20160824


Enhancing central nervous system (CNS) myelin regeneration is recognized as an important strategy to ameliorate the devastating consequences of demyelinating diseases such as multiple sclerosis. Previous findings have indicated that myelin proteins, which accumulate following demyelination, inhibit remyelination by blocking the differentiation of rat oligodendrocyte progenitor cells (OPCs) via modulation of PKCα. We therefore screened drugs for their potential to overcome this differentiation bl  ...[more]

Similar Datasets

| S-EPMC5286209 | biostudies-literature
| S-EPMC7116742 | biostudies-literature
| S-EPMC4465544 | biostudies-other
| S-EPMC8448846 | biostudies-literature
| S-EPMC1636566 | biostudies-literature
| S-EPMC5550580 | biostudies-other
| S-EPMC4135430 | biostudies-literature
2015-07-16 | PXD001285 | Pride
| S-EPMC9752826 | biostudies-literature
| S-EPMC5532330 | biostudies-literature